Why Are People Injecting Themselves with Peptides? The New Yorker BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & FDA to weigh easing limits on unproven peptides Analysis: The peptide problem: Hype is outrunning the evidence McMaster News When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to weigh easing limits on unproven peptides promoted by RFK Jr.